The estimated Net Worth of Monica L. Brady is at least $390 millier dollars as of 23 May 2022. Ms. Brady owns over 39,250 units of ProPhase Labs Inc stock worth over $126,031 and over the last 6 years she sold PRPH stock worth over $0. In addition, she makes $263,701 as Chief Financial Officer at ProPhase Labs Inc.
Sign up
Ms. Brady PRPH stock SEC Form 4 insiders trading
Monica has made over 1 trades of the ProPhase Labs Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 39,250 units of PRPH stock worth $98,910 on 23 May 2022.
The largest trade she's ever made was exercising 39,250 units of ProPhase Labs Inc stock on 23 May 2022 worth over $98,910. On average, Monica trades about 9,813 units every 0 days since 2018. As of 23 May 2022 she still owns at least 46,678 units of ProPhase Labs Inc stock.
You can see the complete history of Ms. Brady stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Monica Brady biography
Monica L. Brady serves as Chief Financial Officer of the Company. She has served as our Chief Financial Officer since January 16, 2019. Prior to serving as our Chief Financial Officer, Ms. Brady served as our Chief Accounting Officer beginning September 2017 and our Director of Finance from 2009 to September 2017.
What is the salary of Monica Brady?
As the Chief Financial Officer of ProPhase Labs Inc, the total compensation of Monica Brady at ProPhase Labs Inc is $263,701. There are 1 executives at ProPhase Labs Inc getting paid more, with Ted William Karkus having the highest compensation of $445,000.
How old is Monica Brady?
Monica Brady is 41, she's been the Chief Financial Officer of ProPhase Labs Inc since 2019. There are 5 older and 1 younger executives at ProPhase Labs Inc. The oldest executive at ProPhase Labs Inc is Louis Gleckel, 64, who is the Independent Director.
Insiders trading at ProPhase Labs Inc
Over the last 15 years, insiders at ProPhase Labs Inc have traded over $6,868,501 worth of ProPhase Labs Inc stock and bought 2,996,691 units worth $4,189,802 . The most active insiders traders include Braden Michael Leonard, Ted William Karkus et James T Mccubbin. On average, ProPhase Labs Inc executives and independent directors trade stock every 98 days with the average trade being worth of $586,896. The most recent stock trade was executed by Ted William Karkus on 1 February 2023, trading 500,000 units of PRPH stock currently worth $300,000.
What does ProPhase Labs Inc do?
prophase labs is a diversified natural health medical science company. for more information visit us at www.prophaselabs.com.
What does ProPhase Labs Inc's logo look like?
Complete history of Ms. Brady stock trades at ProPhase Labs Inc
ProPhase Labs Inc executives and stock owners
ProPhase Labs Inc executives and other stock owners filed with the SEC include:
-
Ted William Karkus,
Chairman & CEO -
Monica Brady,
Chief Financial Officer -
Ted Karkus,
Chairman of the Board, Chief Executive Officer -
Monica Brady,
Chief Financial Officer -
Warren Hirsch,
Independent Director -
Louis Gleckel,
Independent Director -
Jason Barr,
Independent Director -
Sergio Miralles,
Exec. VP & Chief Information Officer of ProPhase Diagnostics -
Sam A. Beeler,
Chief Strategy Officer of Precision Medicine -
Jason Karkus,
Exec. VP & Co-COO -
Alice Lioi,
Exec. VP & Co-COO -
Mark S Leventhal,
Director -
Mark Shawn Frank,
Director -
James T Mccubbin,
Director -
Mark A. Burnett,
Director -
Braden Michael Leonard,
10% owner -
Guy J Quigley,
10% owner -
Robert V Jr Cuddihy,
Chief Operating Officer -
John De Shazo,
Director -
Jed Latkin,
Director -
Robert A. Jr. Morse,
CHIEF FINANCIAL OFFICER